Back
Open Access

SGLT2 inhibitors in HFrEF, a meta-analytical approach.

Session: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
Topic: Treatment
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant
Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
100 presentations
4 followers

4 more presentations in this session

Introduction.

Speaker: Professor J. Butler (Dallas, US)

Access
Video
Thumbnail

EMPEROR-REDUCED Trial: main results.

Speaker: Doctor M. Packer (Dallas, US)

Access
Video
Thumbnail

Panel discussion

Speaker: Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US) Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access
Video
Thumbnail

Conclusion.

Speaker: Professor M. Packer (Dallas, US)

Access
Video
Thumbnail

Access the full session

New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Speakers: Professor F. Zannad, Professor J. Butler, Doctor M. Packer, Professor G. Filippatos, Professor J. Butler...
Access
Video
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb